Visual loss with optic atrophy is common in osteopetrosis. The efficacy of optic nerve decompression in patients with osteopetrosis is still controversial. The purpose of this study is to report that visual deterioration in osteopetrosis can be completely reversed by early optic nerve decompression. An 8-year-old female patient with osteopetrosis was found to have reduced visual acuity on routine ophthalmologic examination. Extensive optic nerve decompression was performed. It not only included unroofing the optic canal, but also drilling away bone on both sidewalls of the optic nerve. Both optic nerves were decompressed during the same surgical procedure. Progressive loss of vision associated with osteopetrosis can be prevented by optic nerve decompression in the early stage of visual deterioration. When managing patients with osteopetrosis, the importance of careful and regular assessment of visual function should be stressed.

1.
Zetterström R: Osteopetrosis (Marble bone disease): Clinical and pathological review. Mod Probl Paediatr 1957;3:488–508.
2.
Consul BN, Kulshresthra OP, Sethi PK: Osteopetrosis. Am J Ophthalmol 1964;58:686–690.
3.
Ellis PP, Jackson WE: Osteopetrosis: A clinical study of optic nerve involvement. Am J Ophthalmol 1962;53:943–953.
4.
Van Waardenburg PJ: Different types of hereditary optic atrophy. Acta Genet Med Gemellol 1957;7:287–290.
5.
Vrabec F, Sedlackova J: Neuro-histological findings in osteopetrosis (Albers-Schonberg disease). Br J Ophthalmol 1964;48:218–222.
6.
Thompson DA, Kriss A, Taylor D, Russell EI, Hodgkins P, Morgan G, Vellodi A, Gerritsen EJ: Early VEP and ERG evidence of visual dysfunction in autosomal recessive osteopetrosis. Neuropediatrics 1998;29:137–144.
7.
Keith CG: Retinal atrophy in osteopetrosis. Arch Ophthalmol 1968;79:234–241.
8.
Hoyt CS, Billson FA: Visual loss in osteopetrosis. Am J Dis Child 1979;133:955–958.
9.
Al Mefty O, Fox JL, Al Rodhan N, Dew JH: Optic nerve decompression in osteopetrosis. J Neurosurg 1988;68:80–84.
10.
Haines SJ, Erickson DL, Wirtschafter JD: Optic nerve decompression for osteopetrosis in early childhood. Neurosurgery 1988;23:470–475.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.